He Wei, Tang Panli, Lv Hongbin, Qiao Lifeng
Department of Ophthalmology, Sichuan Taikang Hospital, Chengdu, China.
Department of Cardiothoracic Surgery, Sichuan Taikang Hospital, Chengdu, China.
Front Med (Lausanne). 2024 Mar 19;11:1364751. doi: 10.3389/fmed.2024.1364751. eCollection 2024.
Leber's idiopathic stellate neuroretinitis (LISN) is a rare disease characterized by disk edema, peripapillary and macular hard exudates, and often, the presence of vitreous cells. To enhance clinical understanding of the disease, a retrospective analysis was conducted on a patient diagnosed with LISN at our hospital, and discussions were held regarding its diagnosis and treatment.
We reviewed the medical records of a 26-year-old male patient whose main complaint was a decrease in visual acuity of both eyes for 4 days, which had worsened over the last day. After systemic examination, fundus fluorescein angiography, and indocyanine green angiography, the patient was diagnosed with LISN in both eyes. After treatment with glucocorticoids, the patient's vision showed a significant improvement.
Upon admission, the visual acuity of both eyes was: VOD 0.05, VOS 0.25. After 5 days of treatment, the visual acuity of both eyes was: VOD 0.25, VOS 0.4. After 1 month of follow-up, the visual acuity of both eyes was: VOD 0.4, VOS 0.6. After 5 months of follow-up, the patient's vision improved to VOD 0.6, VOS 0.8.
The cause of LISN remains unidentified. It is essential to rule out diseases exhibiting similar clinical signs but possessing a clear etiology. The primary treatment approach involves glucocorticoid-based anti-inflammatory therapy, potentially supplemented with antibiotics, antivirals, vasodilators, and traditional Chinese medicine. This disease is usually self-limiting and generally carries a favorable prognosis.
莱伯特发性星状神经视网膜炎(LISN)是一种罕见疾病,其特征为视盘水肿、视乳头周围及黄斑区硬性渗出,且常伴有玻璃体细胞。为增强对该疾病的临床认识,我们对我院一名诊断为LISN的患者进行了回顾性分析,并对其诊断和治疗进行了讨论。
我们回顾了一名26岁男性患者的病历,其主要诉求为双眼视力下降4天,且在最后一天有所加重。经过全身检查、眼底荧光血管造影和吲哚菁绿血管造影后,该患者被诊断为双眼LISN。经糖皮质激素治疗后,患者视力有显著改善。
入院时,双眼视力为:右眼0.05,左眼0.25。治疗5天后,双眼视力为:右眼0.25,左眼0.4。随访1个月后,双眼视力为:右眼0.4,左眼0.6。随访5个月后,患者视力提高至右眼0.6,左眼0.8。
LISN的病因尚不明确。必须排除具有相似临床体征但病因明确的疾病。主要治疗方法为基于糖皮质激素的抗炎治疗,可能辅以抗生素、抗病毒药物、血管扩张剂和中药。这种疾病通常为自限性,总体预后良好。